|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/13 | |
| A61K 31/195 | |||
| A61K 31/20 | |||
| A61K 31/201 | |||
| A61K 31/235 | |||
| A61K 31/35 | |||
| A61K 31/352 | |||
| A61K 31/70 | |||
| A61K 38/05 | |||
| A61K 38/22 | |||
| A61K 38/26 | |||
| A61P 1/00 | |||
| A61P 3/00 | |||
| A61P 19/00 | |||
| A61P 43/00 |
| (11) | Number of the document | 2421524 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10767661.1 |
| Date of filing the European patent application | 2010-04-20 | |
| (97) | Date of publication of the European application | 2012-02-29 |
| (45) | Date of publication and mention of the grant of the patent | 2018-08-08 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2010/031793 |
| Date | 2010-04-20 |
| (87) | Number | WO 2010/123930 |
| Date | 2010-10-28 |
| (30) | Number | Date | Country code |
| 170657 P | 2009-04-20 | US |
| (72) |
BARON, Alain, US
BROWN, Martin, R., US
JONES, Christopher, R.G., US
|
| (73) |
Elcelyx Therapeutics, Inc.,
11975 El Camino Real Suite 305, San Diego, CA 92130,
US
|
| (54) | CHEMOSENSORY RECEPTOR LIGAND-BASED THERAPIES |
| CHEMOSENSORY RECEPTOR LIGAND-BASED THERAPIES |